Table 1 The IC50 of Ibr-7 and ibrutinib in PANC-1 and Capan2 cells
From: The Ibr-7 derivative of ibrutinib radiosensitizes pancreatic cancer cells by downregulating p-EGFR
Cell line | Ibrutinib (μmol/L) | Ibr-7 (μmol/L) |
|---|---|---|
PANC-1 | 20.8 | 1.7 |
Capan2 | 29.6 | 2.5 |
From: The Ibr-7 derivative of ibrutinib radiosensitizes pancreatic cancer cells by downregulating p-EGFR
Cell line | Ibrutinib (μmol/L) | Ibr-7 (μmol/L) |
|---|---|---|
PANC-1 | 20.8 | 1.7 |
Capan2 | 29.6 | 2.5 |